Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...

(Removes erroneous reference to Singapore in first paragraph and headline) FRANKFURT, Sept 28 - German COVID‑19 vaccine maker BioNTech said on Monday that it would close German sites that it has ...

Pfizer is still looking at building a business beyond COVID-19. Moderna (MRNA) turned mRNA COVID-19 drugs into a potential cancer vaccine, sending the stock to multi-year highs with the stock trading ...

Let's start with BioNTech's recent announcement of Phase 2 clinical trial results for autogene cevumeran, an mRNA-based personalized cancer vaccine for certain patients with colorectal cancer. The ...

Volatus Aerospace: Countercyclical Buying Opportunity!? Drone stocks continue to struggle on the stock market. However, there should be no doubt about the industry’s sustainably positive future ...

As the fall approaches, it’s time to think about respiratory virus season and how to protect yourself. COVID-19 cases are already rising in most parts of the country as a late summer wave sweeps ...

It isn't all that surprising that BMO Capital Markets is now significantly less optimistic about BioNTech's near-term prospects than it once was. The global demand for BioNTech's COVID-19 vaccines ...

BioNTech said it would proceed with the closure of sites after it couldn't reach agreements to sell the facilities. "Despite the intensive efforts of all parties involved and a broad-based sales ...

City officials announced late Tuesday that the frozen zone around the unstable Manhattan building has been reduced, allowing some pedestrians and traffic back into the area. Ahmed Tigani, commissioner ...